ReviewCurrent oncology reports2021

Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab Therapy.

Alexandra Lainé et al.PubMed ↗Publisher ↗

No numbers read from the abstract.